Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Disease

US:Argentine rock great Carlos 'Indio' Solari dies aged 77

Rock great Carlos Alberto Solari, an Argentine singer-songwriter known as "the Indio", has died after a decade-long struggle with Parkinson's disease.

AAP

Argentine rock great Carlos 'Indio' Solari dies aged 77

Rock great Carlos Alberto Solari, an Argentine singer-songwriter known as "the Indio", has died after a decade-long struggle with Parkinson's disease.

AAP

Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing to launch Auvelity in Alzheimer’s disease agitation this month while continuing to expand the drug’s use in major depressive disorder and advance a broad central nervous system pipeline. Speaking at a Jefferies fireside chat

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Argentina traps, tests rats as hantavirus probe expands

Argentina is expanding its investigation into a hantavirus outbreak on a cruise ship, sending teams to trap and test rats in Mendoza.

AAP

London researchers find lymph node change could indicate breast cancer risk

New research could help identify people who are at higher or lower risk of breast cancer spreading

Evening Standard

Researchers uncover new way to identify patients with high breast cancer risk

Experts say the findings, over the structural changes within lymph nodes, can guide treatment decisions

The Independent UK

Ebola outbreak in Central Africa could reach 20,000 cases without strong public health measures

The Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are isolated to slow the spread

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands

Assembly Biosciences (NASDAQ:ASMB) is awaiting a key development plan from partner Gilead Sciences for its herpes simplex virus programs while advancing ABI-6250 into multiple liver disease indications, Chief Executive Officer Jason Okazaki said during a Jefferies biotech event. Okazaki said 2024 w

MarketBeat

What is Alzheimer’s disease? The symptoms and causes explained after Jon Snow diagnosis

Alzheimer's disease, a physical illness that progressively damages the brain, stands as the most prevalent cause of dementia in the UK

The Independent UK

“Your Sign To Stop Now”: Woman’s Story Stuns As She Shares Experience With Liver Failure Due To Drinking

“That is my drink for however long it lasts me,” the woman explained in a video before her liver transplant. “I don’t measure, I just pour.”

Bored Panda

Former Channel 4 News presenter Jon Snow diagnosed with Alzheimer’s disease

Jon Snow is set to share his experience in a Channel 4 documentary

The Independent UK

Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data

Arvinas (NASDAQ:ARVN) management outlined a more selective development strategy at a Jefferies-hosted investor discussion, emphasizing internal investment in neurological and oncology programs where the company believes it can create differentiated therapies, while seeking partners for assets that m

MarketBeat

Anastacia says she is ‘very proud’ of her breast cancer diagnoses

The pop icon says that the disease has allowed her ‘spread more attention and information about what’s happening 10 years after the first cancer’

The Independent UK

Norway’s Crown Princess placed on lung transplant waiting list

Norway's Crown Princess Mette-Marit has been placed on the waiting list for a lung transplant following a serious deterioration of her chronic lung disease. Euronews Health explains the background for such a procedure.

Euronews

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

RFK Jr. Wants to Access Medical Data of All Americans To Study Vaccines And Autism Links

Robert F. Kennedy Jr. seeks access to Americans' medical records to explore vaccine-autism links, sparking privacy and data use concerns.

Medical Daily

Six Days Before World Cup Kickoff, New York Confronts the Most Complex Public Health Alert Landscape Ever Seen in the U.S.

Six days before the 2026 FIFA World Cup, New York faces five simultaneous public health alerts, testing preparedness amid an influx of global visitors.

Medical Daily

With Nation's Highest Diabetes Rate, San Antonio Faces Major Shift as Medicare Prepares $50 Wegovy Coverage

With diabetes rates among the highest in the U.S., San Antonio could see major change as Medicare's new $50 Wegovy coverage begins July 1, expanding access for eligible residents.

The Conversation

Ebola: vaccines alone won’t stop an outbreak – here’s what else is needed

Tensions have recently emerged around the Ebola response in eastern Democratic Republic of the Congo (DRC). These tensions have manifested in a series of incidents, including the burning of an Ebola treatment facility in Mongbwalu, confrontations involving families seeking to reclaim the bodies of relatives who had died from the…

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Norway's crown princess on list for lung transplant

Crown Princess Mette-Marit's "life-threatening lung disease has worsened and the Norwegian royal has been placed on the list for a transplant.

The Times of India

World's first AI-designed vaccine developed by UK scientists enters human trials

A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and Basecamp Research, this initiative showcases AI's potential to drastically accelerate vaccine development for emerging infectious diseases. The trial aims to assess safety and immune response, potentially ushering…

The Economic Times

Sleeping more than 8 hours? Senior Neurologist at Apollo Hospitals explains why it may signal a health issue

New research reveals that both too little and too much sleep can accelerate biological aging across vital organs. A study of nearly 500,000 people found a 'sweet spot' of 6.4 to 7.8 hours nightly for healthiest aging. Dr Sudhir Kumar, Senior Consultant Neurologist at Apollo Hospitals in Hyderabad, explains to…

The Guardian - US

A disease of deforestation: how Ebola is linked to the smartphone in your pocket

As demand for cobalt, gold and other minerals grows, mining is accelerating deforestation in the Congo basin – and increasing the risk of deadly Ebola outbreaks

MarketBeat

Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial

Altimmune (NASDAQ:ALT) executives said the company is preparing to begin enrolling patients in the second half of the year for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, while also awaiting data from related alcohol-associated liver disease programs.

MarketBeat

Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment

Aldeyra Therapeutics (NASDAQ:ALDX) Chief Executive Todd Brady said the company expects near-term feedback from the U.S. Food and Drug Administration on its dry eye disease candidate reproxalap, following a third complete response letter tied to efficacy questions. Speaking at a Jefferies fireside c

MarketBeat

Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near

Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement after the TDAPA period and several renal-disease pipeline programs during a fireside chat at the Jefferies 2026 Global Healthcare Conference. Erik, Akebia’s chief financial offic

1 … 30 31 32 33

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Oxford

183 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.